These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19328795)

  • 121. ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells.
    Lima WR; Parreira KS; Devuyst O; Caplanusi A; N'kuli F; Marien B; Van Der Smissen P; Alves PM; Verroust P; Christensen EI; Terzi F; Matter K; Balda MS; Pierreux CE; Courtoy PJ
    J Am Soc Nephrol; 2010 Mar; 21(3):478-88. PubMed ID: 20133480
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA.
    Sourisseau T; Georgiadis A; Tsapara A; Ali RR; Pestell R; Matter K; Balda MS
    Mol Cell Biol; 2006 Mar; 26(6):2387-98. PubMed ID: 16508013
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Zebrafish krüppel-like factor 4a represses intestinal cell proliferation and promotes differentiation of intestinal cell lineages.
    Li IC; Chan CT; Lu YF; Wu YT; Chen YC; Li GB; Lin CY; Hwang SP
    PLoS One; 2011; 6(6):e20974. PubMed ID: 21687630
    [TBL] [Abstract][Full Text] [Related]  

  • 124. The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repression of AML1/Runx1.
    Buchert M; Darido C; Lagerqvist E; Sedello A; Cazevieille C; Buchholz F; Bourgaux JF; Pannequin J; Joubert D; Hollande F
    Gastroenterology; 2009 Jul; 137(1):156-64, 164.e1-3. PubMed ID: 19328795
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 126. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis.
    Kurokawa M
    Int J Hematol; 2006 Aug; 84(2):136-42. PubMed ID: 16926135
    [TBL] [Abstract][Full Text] [Related]  

  • 127. RUNX1: an emerging therapeutic target for cardiovascular disease.
    Riddell A; McBride M; Braun T; Nicklin SA; Cameron E; Loughrey CM; Martin TP
    Cardiovasc Res; 2020 Jul; 116(8):1410-1423. PubMed ID: 32154891
    [TBL] [Abstract][Full Text] [Related]  

  • 128.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 129.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 130.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 7.